Navigation Links
LaserLock Technologies Files for Provisional Patent Enabling Mobile Phones with Anti-Counterfeiting Technology
Date:2/20/2013

PHILADELPHIA, Feb. 20, 2013 /PRNewswire/ -- LaserLock Technologies, Inc. (OTCBB: LLTI), a global leader in providing state-of-the-art authentication solutions to governments, pharmaceuticals, high-end retailers, and casinos announced it has filed a provisional patent application for a Characteristic Verification System (CVS) enabling smart phones to simultaneously identify counterfeit products and protect against identity fraud. The CVS is a groundbreaking technology that sets a new standard in brand protection by combining LaserLock's proven product authentication expertise with its recently acquired VerifyMe™ human authentication technology.  

Acquired by LaserLock Technologies in December 2012, VerifyMe™ is a biometric verification system that uses a smartphone platform and a variety of methods to quickly and accurately prove the identity of any human being. It can also uniquely serialize individual products allowing complete verification of provenance, pedigree and movement.  The new solution benefits from the near ubiquitous penetration of smart phones with integrated cameras and artificial light sources to create advanced inspection tools that can be made available at no additional cost.

"LaserLock's new CVS provisional patent application is uniquely well-suited to take advantage of the increasing demand for more effective, more economical and more efficient authentication technology along supply chains," said Neil Alpert , President of LaserLock Technologies. "This provisional patent application is a potential game-changer for our company and our industry."

The Characteristic Verification System utilizes technologies present in virtually all smartphones to capture both overt and covert anti-counterfeiting measures on any given product, as well as verify the identity of the person performing that action. Its applications range from protecting the most complex and sensitive supply chains to protecting the integrity of high-value retail goods.

"As more industries demand both human and product authentication simultaneously, LaserLock is positioned to assume a leadership role in this arena," said Michael Sonnenreich , Chairman of LaserLock Technologies' Board of Directors. "Just last week, the Institute of Medicine recommended that the United States Congress authorize and fund a mandatory track-and-trace program in the pharmaceutical industry that our technology is already designed to achieve."

Additionally, LaserLock will be releasing VerifyMe™ applications for Android, BlackBerry, iOS and Windows mobile devices including phones and tablets.

ABOUT LASERLOCK TECHNOLOGIES, INC.

LaserLock Technologies, Inc. based in Bala Cynwyd, PA is publicly traded on the OTC Market under the ticker symbol "LLTI". The Company markets security technology to protect pharmaceuticals, high-end retail goods, the casino industry, documents and branded products from counterfeiting. To learn more, visit us at www.laserlocktech.com or follow us on Twitter @LaserLockTech.

MEDIA INQUIRIES
Sarah Jane Scruggs
Sage Communications (for LaserLock Technologies)
703-207-0435
sarahs@aboutsage.com

INVESTOR RELATIONS
LaserLock Technologies
IR@laserlocktech.com

 


'/>"/>
SOURCE LaserLock Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Going negative: Stanford scientists explore new technologies that remove atmospheric CO2
2. New modeling approach transforms imaging technologies
3. Life Technologies ayudará a identificar 20.000 restos humanos encontrados en fosas comunes en Libia
4. New supercomputer coming to EMSL this summer, supplied by Atipa Technologies
5. UT Dallas researchers awarded $4.3 million to create next-generation technologies
6. ASU partners with Life Technologies on US DHHS funded project to rapidly assess radiation dose
7. Lyncean Technologies Inc. sells Compact Light Source to Munich biomedical-imaging research center
8. NREL researchers use imaging technologies to solve puzzle of plant architecture
9. New energy technologies promise brighter future
10. Cross Match Technologies Undoubtedly Offers the Highest Value to Customers in the North American Biometrics Market, Says Frost & Sullivan
11. Life Technologies to supply new Covaris DNA fragmenting products for Ion Torrent Semiconductor Sequencers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... PROVIDENCE, R.I. , March 31, 2016  Genomics ... leadership of founding CEO, Barrett Bready , M.D., ... addition, members of the original technical leadership team, including ... Vice President of Product Development, Steve Nurnberg and Vice ... have returned to the company. Dr. Bready ...
(Date:3/23/2016)... 2016 Einzigartige ... und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler Kommunikationsdienste, ... SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie einzusetzen. ... Möglichkeit angeboten, im Rahmen mobiler Apps neben ...
(Date:3/22/2016)... and SANDY, Utah , March ... operates the highest sample volume laboratory in ... and UNIConnect, leaders in clinical sequencing informatics and molecular ... of a project to establish the informatics infrastructure for ... NSO has been contracted by the Ontario Ministry ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica ... in people with peritoneal or pleural mesothelioma. Their findings are the subject of a ... , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is pleased to announce the launch of their brand, UP4™ Probiotics, into Target ... over 35 years, is proud to add Target to its list of well-respected ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
Breaking Biology Technology: